• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素型前列腺素D合酶是稳定型冠状动脉疾病严重程度的有力生物标志物。

Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease.

作者信息

Inoue Teruo, Eguchi Yutaka, Matsumoto Tetsuya, Kijima Yoshiyuki, Kato Yoji, Ozaki Yukio, Waseda Katsuhisa, Oda Hiroshi, Seiki Kosuke, Node Koichi, Urade Yoshihiro

机构信息

Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan.

出版信息

Atherosclerosis. 2008 Dec;201(2):385-91. doi: 10.1016/j.atherosclerosis.2008.03.010. Epub 2008 Mar 16.

DOI:10.1016/j.atherosclerosis.2008.03.010
PMID:18436228
Abstract

Lipocalin-type prostaglandin D synthase (L-PGDS), which is responsible for the biosynthesis of prostaglandin (PG) D(2), has been found to be present in the atherosclerotic plaque of the human coronary artery and also to be detectable in human serum. This multicenter cooperative study was designed to establish the diagnostic value of measuring serum L-PGDS for coronary artery disease. The study included 1013 consecutive patients suspected of having stable coronary artery disease who underwent diagnostic coronary angiography. Peripheral blood was collected prior to angiography. The serum level of L-PGDS, as determined by a sandwich ELISA, was 58.1 +/- 2.2, 62.0 +/- 1.8 and 80.6 +/- 2.6 microg/dl for patients with no stenotic lesion (N, n=241), single-vessel coronary artery disease (S, n=351), and multi-vessel coronary artery disease (M, n=421), respectively (N vs. S; P<0.001, S vs. M; P<0.01, N vs. M; P<0.001). Multiple regression analysis indicated that the most powerful independent predictor of the coronary severity score (Gensini Score) was the L-PGDS level (R=0.55, P<0.0001). The serum L-PGDS level is suitable to evaluate the severity of coronary artery disease. The measurement of serum L-PGDS can be a strategy for screening of stable coronary artery disease prior to coronary angiography.

摘要

脂联素型前列腺素D合成酶(L-PGDS)负责前列腺素(PG)D2的生物合成,已发现其存在于人类冠状动脉的动脉粥样硬化斑块中,并且在人血清中也可检测到。这项多中心合作研究旨在确定检测血清L-PGDS对冠状动脉疾病的诊断价值。该研究纳入了1013例连续怀疑患有稳定型冠状动脉疾病并接受诊断性冠状动脉造影的患者。在血管造影术前采集外周血。通过夹心ELISA测定,无狭窄病变患者(N组,n = 241)、单支冠状动脉疾病患者(S组,n = 351)和多支冠状动脉疾病患者(M组,n = 421)的血清L-PGDS水平分别为58.1±2.2 μg/dl、62.0±1.8 μg/dl和80.6±2.6 μg/dl(N组与S组比较,P<0.001;S组与M组比较,P<0.01;N组与M组比较,P<0.001)。多元回归分析表明,冠状动脉严重程度评分(Gensini评分)最有力的独立预测指标是L-PGDS水平(R = 0.55,P<0.0001)。血清L-PGDS水平适用于评估冠状动脉疾病的严重程度。检测血清L-PGDS可作为冠状动脉造影术前筛查稳定型冠状动脉疾病的一种策略。

相似文献

1
Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease.脂联素型前列腺素D合酶是稳定型冠状动脉疾病严重程度的有力生物标志物。
Atherosclerosis. 2008 Dec;201(2):385-91. doi: 10.1016/j.atherosclerosis.2008.03.010. Epub 2008 Mar 16.
2
Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis.冠状动脉成形术后血清前列腺素D合酶水平可能预测再狭窄的发生。
Thromb Haemost. 2001 Jan;85(1):165-70.
3
Association of serum lipocalin-type prostaglandin D synthase levels with subclinical atherosclerosis in untreated asymptomatic subjects.未治疗的无症状受试者血清脂质运载蛋白型前列腺素D合成酶水平与亚临床动脉粥样硬化的关联
Hypertens Res. 2008 Oct;31(10):1931-9. doi: 10.1291/hypres.31.1931.
4
A urine biomarker for severe obstructive sleep apnoea patients: lipocalin-type prostaglandin D synthase.尿生物标志物用于严重阻塞性睡眠呼吸暂停患者:脂氧素型前列腺素 D 合酶。
Eur Respir J. 2013 Dec;42(6):1563-74. doi: 10.1183/09031936.00133512. Epub 2012 Dec 6.
5
Lipocalin-type prostaglandin D synthase is associated with coronary vasospasm and vasomotor reactivity in response to acetylcholine.脂氧素 A4 合酶与冠状动脉痉挛及乙酰胆碱引起的血管舒缩反应有关。
Circ J. 2011;75(4):897-904. doi: 10.1253/circj.cj-10-0902. Epub 2011 Feb 11.
6
Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.中枢神经系统脂钙蛋白型前列腺素 D2 合酶与肥胖人群的食欲肽、内脏肥胖和下丘脑-垂体-肾上腺轴标志物相关。
J Neuroendocrinol. 2011 Jun;23(6):501-7. doi: 10.1111/j.1365-2826.2011.02128.x.
7
Lipocalin-type prostaglandin D synthase is not a biomarker of atherosclerotic manifestations.
Scand J Clin Lab Invest. 2014 Apr;74(3):219-27. doi: 10.3109/00365513.2013.877595. Epub 2014 Jan 23.
8
Seminal plasma lipocalin-type prostaglandin D synthase: a potential new marker for the diagnosis of obstructive azoospermia.精浆脂钙素型前列腺素D合成酶:一种用于阻塞性无精子症诊断的潜在新标志物。
J Urol. 2008 Mar;179(3):1077-80. doi: 10.1016/j.juro.2007.10.070. Epub 2008 Jan 18.
9
Lipocalin-type prostaglandin D synthase levels are associated with the severity of pulmonary embolism.脂联素型前列腺素D合成酶水平与肺栓塞的严重程度相关。
Heart Vessels. 2020 Jul;35(7):996-1002. doi: 10.1007/s00380-020-01568-2. Epub 2020 Feb 19.
10
Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase.脂联素型前列腺素 D 合酶对马拉硫磷诱导的人神经母细胞瘤 SH-SY5Y 细胞凋亡的预防作用。
J Neurochem. 2012 Jan;120(2):279-91. doi: 10.1111/j.1471-4159.2011.07570.x. Epub 2011 Nov 24.

引用本文的文献

1
Data-Independent Acquisition Proteomics Identifies Plasma Prostaglandin-H2 D-Isomerase as an Early Diagnostic Biomarker for STEMI and NSTEMI.数据非依赖采集蛋白质组学鉴定血浆前列腺素-H2 D-异构酶作为ST段抬高型心肌梗死和非ST段抬高型心肌梗死的早期诊断生物标志物。
Mol Cell Proteomics. 2025 May 23;24(7):100996. doi: 10.1016/j.mcpro.2025.100996.
2
Assessment of Inflammatory and Oxidative Stress Biomarkers for Predicting of Patients with Asymptomatic Carotid Artery Stenosis.用于预测无症状性颈动脉狭窄患者的炎症和氧化应激生物标志物评估
J Clin Med. 2025 Jan 24;14(3):755. doi: 10.3390/jcm14030755.
3
Early predictive value of lipocalin-type prostaglandin D synthase for 28-day mortality in cardiac arrest patients: study protocol for a prospective study.
脂氧素 A4 合酶对心脏骤停患者 28 天死亡率的早期预测价值:一项前瞻性研究的研究方案。
BMJ Open. 2024 Jun 5;14(6):e083136. doi: 10.1136/bmjopen-2023-083136.
4
Prostanoids in Cardiac and Vascular Remodeling.前列腺素在心脏和血管重构中的作用。
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):558-583. doi: 10.1161/ATVBAHA.123.320045. Epub 2024 Jan 25.
5
Lipocalin family proteins and their diverse roles in cardiovascular disease.脂质运载蛋白家族蛋白及其在心血管疾病中的多种作用。
Pharmacol Ther. 2023 Apr;244:108385. doi: 10.1016/j.pharmthera.2023.108385. Epub 2023 Mar 24.
6
Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D Synthase as a Multifunctional Lipocalin.脂联素型前列腺素D合成酶作为一种多功能脂联素的生化与结构特征、基因调控、生理、病理及临床特征
Front Physiol. 2021 Oct 22;12:718002. doi: 10.3389/fphys.2021.718002. eCollection 2021.
7
Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.扩展血液透析作为一种清除尿毒症毒素的当前策略。
Toxins (Basel). 2021 May 26;13(6):380. doi: 10.3390/toxins13060380.
8
The Effect of Beta-Trace Protein on Diagnosis and Prognosis in Patients with Acute Coronary Syndrome.β-微球蛋白对急性冠脉综合征患者诊断及预后的影响
Cureus. 2020 Feb 28;12(2):e7135. doi: 10.7759/cureus.7135.
9
Prostaglandin D stimulates phenotypic changes in vascular smooth muscle cells.前列腺素 D 可刺激血管平滑肌细胞表型改变。
Exp Mol Med. 2019 Nov 18;51(11):1-10. doi: 10.1038/s12276-019-0330-3.
10
Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice.脂氧素样前列腺素 D 合酶缺失而非造血性前列腺素 D 合酶缺失导致小鼠高血压和血栓形成加速。
J Pharmacol Exp Ther. 2018 Dec;367(3):425-432. doi: 10.1124/jpet.118.250936. Epub 2018 Oct 10.